[1]
Patel, S.D. and Mitchell, E.G. 2023. HYPERPARATHYROIDISM-INDUCED ERYTHROPOIETIN RESISTANCE: IMPLICATIONS FOR CKD MANAGEMENT. International Research Journal of Medical and Pharmaceutical Sciences (IRJMPS). 8, 3 (Oct. 2023), 1–8.